A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period

PHASE4CompletedINTERVENTIONAL
Enrollment

407

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Migraine Disorders
Interventions
DRUG

sumatriptan and naproxen sodium combination tablet

sumatriptan 85mg and naproxen sodium 500mg

DRUG

sumatriptan tablet

sumatriptan 85mg

DRUG

naproxen sodium tablet

Naproxen sodium 500mg

Trial Locations (49)

15236

GSK Investigational Site, Pittsburgh

27103

GSK Investigational Site, Winston-Salem

27405

GSK Investigational Site, Greensboro

27607

GSK Investigational Site, Raleigh

27609

GSK Investigational Site, Raleigh

27612

GSK Investigational Site, Raleigh

28075

GSK Investigational Site, Harrisburg

28105

GSK Investigational Site, Matthews

29464

GSK Investigational Site, Mt. Pleasant

29681

GSK Investigational Site, Simpsonville

30034

GSK Investigational Site, Decatur

30308

GSK Investigational Site, Atlanta

32216

GSK Investigational Site, Jacksonville

33010

GSK Investigational Site, Hialeah

33024

GSK Investigational Site, Pembroke Pines

33143

GSK Investigational Site, Miami

33351

GSK Investigational Site, Sunrise

33702

GSK Investigational Site, St. Petersburg

37203

GSK Investigational Site, Nashville

37620

GSK Investigational Site, Bristol

38018

GSK Investigational Site, Memphis

44122

GSK Investigational Site, Cleveland

45069

GSK Investigational Site, West Chester

49009

GSK Investigational Site, Kalamazoo

60614

GSK Investigational Site, Chicago

63141

GSK Investigational Site, St Louis

65807

GSK Investigational Site, Springfield

67207

GSK Investigational Site, Wichita

72205

GSK Investigational Site, Little Rock

73112

GSK Investigational Site, Oklahoma City

77004

GSK Investigational Site, Houston

78205

GSK Investigational Site, San Antonio

78705

GSK Investigational Site, Austin

80904

GSK Investigational Site, Colorado Springs

84088

GSK Investigational Site, West Jordan

84107

GSK Investigational Site, Salt Lake City

85050

GSK Investigational Site, Phoenix

85224

GSK Investigational Site, Chandler

85234

GSK Investigational Site, Gilbert

85283

GSK Investigational Site, Tempe

85340

GSK Investigational Site, Litchfield Park

90404

GSK Investigational Site, Santa Monica

90620

GSK Investigational Site, Buena Park

91361

GSK Investigational Site, Westlake Village

92660

GSK Investigational Site, Newport Beach

92801

GSK Investigational Site, Anaheim

92805

GSK Investigational Site, Anaheim

92845

GSK Investigational Site, Garden Grove

06001

GSK Investigational Site, Avon

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00792636 - A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period | Biotech Hunter | Biotech Hunter